Table 1 Patient demographics and clinical characteristics
|  | Medical Management N = 3421 | Surgical Management N = 1155 | P value | ||
|---|---|---|---|---|---|
N or Mean | % or SD | N or Mean | % or SD | ||
Age | 63.2 | 13.6 | 64.6 | 13.7 | 0.002 |
Male | 1186 | 34.7% | 414 | 35.8% | 0.47 |
Race | |||||
 Caucasian | 2132 | 62.3% | 777 | 67.3% | 0.007 |
 Black | 230 | 6.7% | 79 | 6.8% |  |
 Asian/Pacific Islander | 394 | 11.5% | 129 | 11.2% |  |
 Hispanic | 587 | 17.1% | 149 | 12.9% |  |
 Other/Unknown | 78 | 2.3% | 21 | 1.8% |  |
Elixhauser Comorbidity Index Score | 19.3 | 7.9 | 21.9 | 9.1 | < 0.0001 |
Ascites | 445 | 13.0% | 164 | 14.2% | 0.30 |
DNR Status | 443 | 13.0% | 128 | 11.1% | 0.10 |
Primary Cancer Diagnosis | |||||
 Colorectal | 1046 | 30.6% | 345 | 29.9% | 0.65 |
 Pancreatic | 164 | 4.8% | 57 | 4.9% | 0.85 |
 Ovarian | 840 | 24.6% | 220 | 19.1% | 0.0001 |
 Foregut and Small Bowel | 213 | 6.2% | 72 | 6.2% | 0.99 |
 Hepatobiliary | 78 | 2.3% | 19 | 1.7% | 0.20 |
 Lung/Mediastinal | 90 | 2.6% | 38 | 3.3% | 0.24 |
 Nonovarian Urogyn | 395 | 11.6% | 134 | 11.6% | 0.96 |
 Other | 879 | 25.7% | 218 | 18.9% | < 0.0001 |
 Unknown | 509 | 14.9% | 228 | 19.7% | 0.0001 |
Multiple Cancer Diagnoses | 791 | 23.1% | 180 | 15.6% | < 0.0001 |